Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Arch Bronconeumol ; 30(9): 462-4, 1994 Nov.
Article in Spanish | MEDLINE | ID: mdl-8000696

ABSTRACT

We present a case of extrinsic allergic alveolitis due to Penicillium frequentans exposure (suberosis) at a cork factory. Diagnosis was based on clinical history, a restrictive spirometric pattern, evidence of reticular-nodular lung infiltrates on the X-ray, intradermal skin tests with dual reaction and precipitins-positive serum samples in the presence of the P. frequentans fungus. Although the patient refused to submit to a specific bronchial challenge, two natural challenges occurred when he once again happened to handle wet cork after leaving his previous job. The literature referring to this disease is reviewed.


Subject(s)
Aspergillosis, Allergic Bronchopulmonary/etiology , Occupational Diseases/etiology , Penicillium , Adult , Aspergillosis, Allergic Bronchopulmonary/diagnosis , Aspergillosis, Allergic Bronchopulmonary/diagnostic imaging , Humans , Male , Occupational Diseases/diagnosis , Occupations , Radiography , Skin Tests , Spirometry
2.
Allergol Immunopathol (Madr) ; 22(6): 244-9, 1994.
Article in English | MEDLINE | ID: mdl-7892812

ABSTRACT

Three cases with a family history of type II hereditary angioedema (HAE) are presented, together with their progress following treatment with stanozolol. The development of patients with this drug was satisfactory in clinical terms, as it gave rise to virtually no side effects or angioedema episodes. Only patient 3 showed an elevation of hepatic enzyme (SGOT, SGPT) levels in serum, 2 months after starting treatment. C4 values of patient 2 attained sporadic normalization in the first five months of treatment, while the values corresponding to the other two patients remained below normal at all times. The activity of C1 inhibitor (C1-INH) remained below normal in all three cases. In patient 3, it was observed that circulating immunocomplex (CIC) monitoring was, together with clinical progress, a useful method for controlling HAE activity.


Subject(s)
Angioedema/genetics , Complement C1 Inactivator Proteins/deficiency , Complement C2/deficiency , Complement C4/deficiency , Adolescent , Adult , Alanine Transaminase/blood , Angioedema/classification , Angioedema/drug therapy , Angioedema/enzymology , Antifibrinolytic Agents/therapeutic use , Antigen-Antibody Complex/blood , Aspartate Aminotransferases/blood , Creatine Kinase/blood , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Male , Pedigree , Stanozolol/therapeutic use , Tranexamic Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...